Keyphrases
5-year Survival
50%
Cancer Registry
16%
Charlson Comorbidity Index
16%
CO 2
16%
Comorbidity
83%
Comorbidity Scores
16%
Concurrent Chemoradiation
16%
Confidence Interval
33%
Curative Intent
100%
Elderly Patients
33%
Limburg
16%
Little Data
16%
Median Overall Survival
50%
Netherlands
16%
No Significant Difference
16%
Non-small Cell Lung Cancer Patients
100%
Overall Survival
33%
Palliative Intent
16%
Palliative Treatment
33%
Patient Comorbidities
16%
Prospective Cohort Study
100%
Radiotherapy
16%
Sequential Chemotherapy
16%
Sequential Radiotherapy
16%
Stage III Non-small Cell Lung Cancer
100%
INIS
cancer
100%
chemotherapy
9%
comparative evaluations
9%
data
9%
lung cells
100%
morbidity
63%
netherlands
9%
patients
100%
populations
100%
radiations
9%
radiotherapy
18%
Nursing and Health Professions
Cancer Registry
14%
Chemoradiotherapy
14%
Confidence Interval
28%
Elderly Patient
28%
Non Small Cell Lung Cancer
100%
Overall Survival
100%
Palliative Therapy
28%
Radiotherapy
28%
Survival Rate
14%
Medicine and Dentistry
Cancer Registry
14%
Chemoradiotherapy
14%
Elderly Patient
28%
Non Small Cell Lung Cancer
100%
Overall Survival
100%
Radiation Therapy
28%
Survival Rate
14%
Symptomatic Treatment
28%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Registry
14%
Chemoradiation Therapy
14%
Chemotherapy
14%
Non Small Cell Lung Cancer
100%
Overall Survival
100%
Survival Rate
14%